Psoriatic Arthritis Trial, Recruiting NCT02418442 Sponsor: Duke University Condition: Psoriatic Arthritis
Back to Psoriatic Arthritis

Psoriatic Arthritis Trial, Recruiting

NCT02418442
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • Your rheumatic disease (a condition affecting joints, muscles, or connective tissue) must have started before age 16 if you have Juvenile Idiopathic Arthritis (JIA), or before age 19 if you have a different rheumatic disease.
  • You (and/or your parent or legal guardian if needed) must be able to sign a written consent form and be willing to follow the study's procedures.
  • You and/or your parent or legal guardian must be willing to be contacted by the study team in the future.

Who may not be able to join:

  • You are older than 21 years of age at the time of signing up for the trial.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mara L Becker, MD, MSCE, Duke Clinical Research Insitute

Phone: (919) 419-5032

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 July 2015
Est. completion
1 June 2028

Where this trial is recruiting

🇨🇦 Canada 🇮🇱 Israel 🇮🇹 Italy Puerto Rico 🇺🇸 United States

Primary endpoints

Prospectively collect essential data elements from children, adolescents and young adults with pediatric rheumatic diseases; Evaluate the safety of therapeutic agents in persons with pediatric onset rheumatic diseases

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov